Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Asaf Danziger. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Asaf Danziger zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:NVCR / NovoCure Limited | Director | 416 474 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Asaf Danziger. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Asaf Danziger ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-08 |
|
5 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 1 | 416 474 | 0,00 | 10,99 | 11 | 4 577 049 | |
| 2025-07-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 833 | 416 473 | 0,20 | 15,13 | 12 603 | 6 301 236 | |
| 2025-01-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 400 000 | 415 640 | 2 557,54 | ||||
| 2025-01-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 412 | 15 640 | 2,71 | 14,75 | 6 076 | 230 659 | |
| 2024-08-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 1 239 | 15 228 | 8,86 | 12,24 | 15 165 | 186 391 | |
| 2023-07-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 367 | 13 989 | 2,69 | 35,28 | 12 948 | 493 532 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 39 | 13 622 | 0,29 | 62,30 | 2 430 | 848 719 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -187 500 | 13 583 | -93,25 | 108,00 | -20 250 000 | 1 466 964 |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 187 500 | 201 083 | 1 380,40 | 7,15 | 1 340 625 | 1 437 743 |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -500 | 13 583 | -3,55 | 119,99 | -59 994 | 1 629 783 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -1 344 | 14 083 | -8,71 | 119,35 | -160 405 | 1 680 796 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -2 123 | 15 427 | -12,10 | 118,47 | -251 515 | 1 827 658 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -999 | 17 550 | -5,39 | 117,01 | -116 894 | 2 053 545 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -1 395 | 18 549 | -6,99 | 116,06 | -161 906 | 2 152 830 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -3 702 | 19 944 | -15,66 | 115,21 | -426 512 | 2 297 774 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -4 568 | 23 646 | -16,19 | 114,35 | -522 362 | 2 703 977 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -2 000 | 28 214 | -6,62 | 112,86 | -225 726 | 3 184 322 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -8 369 | 30 214 | -21,69 | 111,23 | -930 916 | 3 360 818 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 25 000 | 38 583 | 184,05 | 11,46 | 286 500 | 442 161 |
| 2022-07-07 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 276 | 13 583 | 2,07 | 59,08 | 16 305 | 802 416 | |
| 2022-03-07 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 13 470 | 13 470 | 80,59 | 1 085 547 | 1 085 547 | ||
| 2022-01-12 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 31 | 13 307 | 0,23 | 63,82 | 1 978 | 849 226 | |
| 2021-11-29 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
P - Purchase | 104 | 13 276 | 0,79 | 96,50 | 10 036 | 1 281 134 | |
| 2021-11-29 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
P - Purchase | 1 000 | 13 172 | 8,22 | 103,37 | 103 370 | 1 361 590 | |
| 2021-11-29 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
P - Purchase | 3 870 | 12 172 | 46,62 | 102,36 | 396 133 | 1 245 926 | |
| 2021-07-08 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 118 | 8 302 | 1,44 | 137,12 | 16 180 | 1 138 387 | |
| 2021-04-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -97 973 | 8 184 | -92,29 | 196,34 | -19 236 323 | 1 606 872 |
| 2021-03-02 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | -9 259 | 0 | -100,00 | ||||
| 2021-03-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 9 259 | 206 944 | 4,68 | 149,10 | 1 380 517 | 30 855 350 | |
| 2021-01-08 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 53 | 197 685 | 0,03 | 50,67 | 2 685 | 10 016 501 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -103 955 | 0 | -100,00 | ||||
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -103 955 | 0 | -100,00 | ||||
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -400 | 197 632 | -0,20 | 166,08 | -66 432 | 32 822 525 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -971 | 198 032 | -0,49 | 164,96 | -160 175 | 32 667 161 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -536 | 199 003 | -0,27 | 163,35 | -87 555 | 32 506 742 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -1 700 | 199 539 | -0,84 | 162,35 | -276 000 | 32 395 755 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -4 014 | 201 239 | -1,96 | 161,11 | -646 679 | 32 420 810 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -11 686 | 205 253 | -5,39 | 160,27 | -1 872 915 | 32 895 898 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -4 790 | 216 939 | -2,16 | 159,27 | -762 903 | 34 551 875 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -10 077 | 221 729 | -4,35 | 158,06 | -1 592 811 | 35 047 373 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -23 601 | 231 806 | -9,24 | 157,01 | -3 705 522 | 36 395 165 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -24 973 | 255 407 | -8,91 | 156,08 | -3 897 861 | 39 864 691 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -21 207 | 280 380 | -7,03 | 155,23 | -3 292 005 | 43 523 948 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 103 955 | 301 587 | 52,60 | 22,00 | 2 287 010 | 6 634 914 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 103 955 | 301 587 | 52,60 | 22,00 | 2 287 010 | 6 634 914 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -200 | 197 632 | -0,10 | 166,17 | -33 234 | 32 840 905 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -700 | 197 832 | -0,35 | 165,38 | -115 768 | 32 718 050 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -500 | 198 532 | -0,25 | 164,11 | -82 054 | 32 580 888 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -1 300 | 199 032 | -0,65 | 162,97 | -211 860 | 32 436 046 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -1 426 | 200 332 | -0,71 | 162,17 | -231 259 | 32 488 441 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -3 500 | 201 758 | -1,71 | 160,99 | -563 479 | 32 481 827 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -12 092 | 205 258 | -5,56 | 160,25 | -1 937 743 | 32 892 594 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -4 500 | 217 350 | -2,03 | 159,32 | -716 954 | 34 628 854 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -9 183 | 221 850 | -3,97 | 158,09 | -1 451 777 | 35 073 154 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -24 656 | 231 033 | -9,64 | 157,04 | -3 871 904 | 36 280 729 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -24 286 | 255 689 | -8,67 | 156,09 | -3 790 826 | 39 910 752 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -21 612 | 279 975 | -7,17 | 155,24 | -3 355 047 | 43 463 319 | |
| 2020-09-17 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -103 000 | 207 910 | -33,13 | ||||
| 2020-09-17 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -103 000 | 197 632 | -34,26 | 99,00 | -10 197 000 | 19 565 568 |
| 2020-09-17 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 103 000 | 300 632 | 52,12 | 22,00 | 2 266 000 | 6 613 904 | |
| 2020-07-08 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 284 | 197 632 | 0,14 | 50,40 | 14 315 | 9 961 641 | |
| 2020-03-02 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | -9 259 | 9 259 | -50,00 | ||||
| 2020-03-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 9 259 | 197 348 | 4,92 | 79,45 | 735 628 | 15 679 299 | |
| 2020-02-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | 53 333 | 0 | -100,00 | ||||
| 2020-02-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Share Units |
M - Exercise | 53 333 | 188 089 | 39,58 | 88,26 | 4 707 171 | 16 600 735 | |
| 2020-01-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 155 | 134 756 | 0,12 | 52,58 | 8 150 | 7 085 605 | |
| 2019-11-26 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -103 000 | 310 910 | -24,88 | ||||
| 2019-11-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -103 000 | 134 601 | -43,35 | 95,00 | -9 785 000 | 12 787 095 |
| 2019-11-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 103 000 | 237 601 | 76,52 | 22,00 | 2 266 000 | 5 227 222 |
| 2019-09-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -500 | 134 601 | -0,37 | 92,00 | -46 000 | 12 383 292 | |
| 2019-09-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -65 768 | 135 101 | -32,74 | 91,60 | -6 024 612 | 12 375 792 | |
| 2019-09-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -57 913 | 200 869 | -22,38 | 90,58 | -5 245 586 | 18 194 111 | |
| 2019-07-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 471 | 258 782 | 0,18 | 27,81 | 13 099 | 7 197 245 | |
| 2019-07-02 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -187 500 | 187 500 | -50,00 | ||||
| 2019-07-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -187 500 | 258 311 | -42,06 | 62,15 | -11 653 125 | 16 054 029 |
| 2019-07-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 187 500 | 445 811 | 72,59 | 7,15 | 1 340 625 | 3 187 549 |
| 2019-06-21 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -25 000 | 25 000 | -50,00 | ||||
| 2019-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -25 000 | 258 311 | -8,82 | 61,46 | -1 536 500 | 15 875 794 |
| 2019-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 25 000 | 283 311 | 9,68 | 11,46 | 286 500 | 3 246 744 |
| 2019-06-19 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -190 338 | 0 | -100,00 | ||||
| 2019-06-19 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -190 338 | 258 311 | -42,42 | 59,37 | -11 300 367 | 15 335 924 |
| 2019-06-19 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 190 338 | 448 649 | 73,69 | 14,37 | 2 735 157 | 6 447 086 |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -30 436 | 190 338 | -13,79 | ||||
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -18 203 | 258 311 | -6,58 | 55,74 | -1 014 544 | 14 396 964 | |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -12 233 | 276 514 | -4,24 | 54,89 | -671 420 | 15 176 747 | |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 30 436 | 288 747 | 11,78 | 14,37 | 437 365 | 4 149 294 |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -16 835 | 220 774 | -7,09 | ||||
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -850 | 258 311 | -0,33 | 55,42 | -47 111 | 14 316 887 | |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -15 985 | 259 161 | -5,81 | 54,71 | -874 539 | 14 178 698 | |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 16 835 | 275 146 | 6,52 | 14,37 | 241 919 | 3 953 848 |
| 2019-05-10 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 35 000 | 35 000 | |||||
| 2019-05-10 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 115 060 | 115 060 | |||||
| 2019-03-26 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 44 953 | 44 953 | |||||
| 2019-03-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Share Units |
A - Award | 24 554 | 258 311 | 10,50 | ||||
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -16 268 | 237 609 | -6,41 | ||||
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -6 441 | 233 757 | -2,68 | 56,51 | -363 994 | 13 210 076 | |
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -6 127 | 240 198 | -2,49 | 56,00 | -343 124 | 13 451 568 | |
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -3 700 | 246 325 | -1,48 | 54,64 | -202 168 | 13 459 198 | |
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 16 268 | 250 025 | 6,96 | 14,37 | 233 771 | 3 592 859 |
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -100 000 | 253 877 | -28,26 | ||||
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -6 903 | 233 757 | -2,87 | 56,49 | -389 923 | 13 203 998 | |
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -55 815 | 240 660 | -18,83 | 55,85 | -3 117 156 | 13 440 380 | |
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -37 282 | 296 475 | -11,17 | 54,97 | -2 049 503 | 16 298 120 | |
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 100 000 | 333 757 | 42,78 | 14,37 | 1 437 000 | 4 796 088 |
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -903 | 353 887 | -0,25 | ||||
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -903 | 233 757 | -0,38 | 54,40 | -49 119 | 12 715 212 | |
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 903 | 234 660 | 0,39 | 14,37 | 12 976 | 3 372 064 |
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | -9 260 | 18 518 | -33,34 | ||||
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 9 260 | 233 757 | 4,12 | 52,90 | 489 854 | 12 365 745 | |
| 2019-02-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | -53 333 | 53 333 | -50,00 | ||||
| 2019-02-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 53 333 | 224 497 | 31,16 | 53,38 | 2 846 916 | 11 983 650 | |
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -17 902 | 50 000 | -26,36 | ||||
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -17 902 | 171 164 | -9,47 | 51,46 | -921 237 | 8 808 099 |
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 17 902 | 189 066 | 10,46 | 11,46 | 205 157 | 2 166 696 |
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -32 098 | 67 902 | -32,10 | ||||
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -32 098 | 171 164 | -15,79 | 51,46 | -1 651 763 | 8 808 099 |
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 32 098 | 203 262 | 18,75 | 11,46 | 367 843 | 2 329 383 |
| 2019-01-25 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -88 695 | 0 | -100,00 | ||||
| 2019-01-25 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -88 695 | 171 164 | -34,13 | 47,48 | -4 211 239 | 8 126 867 | |
| 2019-01-25 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 88 695 | 259 859 | 51,82 | 7,48 | 663 439 | 1 943 745 |
| 2019-01-22 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -46 863 | 0 | -100,00 | ||||
| 2019-01-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -13 644 | 171 164 | -7,38 | 46,16 | -629 793 | 7 900 759 | |
| 2019-01-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -33 219 | 184 808 | -15,24 | 45,80 | -1 521 563 | 8 464 946 | |
| 2019-01-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 46 863 | 218 027 | 27,38 | 3,44 | 161 209 | 750 013 |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -100 000 | 46 863 | -68,09 | ||||
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -100 000 | 171 164 | -36,88 | 45,26 | -4 526 400 | 7 747 567 | |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 100 000 | 271 164 | 58,42 | 3,44 | 344 000 | 932 804 |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -100 000 | 146 863 | -40,51 | ||||
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -1 787 | 171 164 | -1,03 | 45,28 | -80 906 | 7 749 450 | |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -98 213 | 172 951 | -36,22 | 45,05 | -4 424 397 | 7 791 270 | |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 100 000 | 271 164 | 58,42 | 3,44 | 344 000 | 932 804 |
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -100 000 | 246 863 | -28,83 | ||||
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -100 000 | 171 164 | -36,88 | 43,49 | -4 348 800 | 7 443 580 | |
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 100 000 | 271 164 | 58,42 | 3,44 | 344 000 | 932 804 | |
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -100 000 | 346 863 | -22,38 | ||||
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -100 000 | 171 164 | -36,88 | 43,52 | -4 352 400 | 7 449 742 | |
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 100 000 | 271 164 | 58,42 | 3,44 | 344 000 | 932 804 | |
| 2019-01-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 264 | 171 164 | 0,15 | 27,20 | 7 181 | 4 655 661 | |
| 2018-07-10 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 795 | 70 113 | 1,15 | 17,26 | 13 718 | 1 209 800 | |
| 2018-06-29 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -70 364 | 69 318 | -50,37 | 32,09 | -2 257 699 | 2 224 137 |
| 2018-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -8 308 | 139 682 | -5,61 | 32,04 | -266 148 | 4 474 727 | |
| 2018-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -621 | 147 990 | -0,42 | 32,00 | -19 872 | 4 735 680 |
| 2018-06-19 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -22 289 | 148 611 | -13,04 | 32,00 | -713 248 | 4 755 552 |
| 2018-06-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -200 | 170 900 | -0,12 | 32,00 | -6 400 | 5 468 800 |
| 2018-06-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -11 720 | 171 100 | -6,41 | 32,00 | -375 040 | 5 475 200 |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | -2 800 | 182 820 | -1,51 | 32,00 | -89 600 | 5 850 240 |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -19 694 | 185 620 | -9,59 | 31,64 | -623 118 | 5 873 017 | |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -28 150 | 205 314 | -12,06 | 30,34 | -854 071 | 6 229 227 | |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -26 782 | 233 464 | -10,29 | 29,31 | -784 980 | 6 842 830 | |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -149 878 | 260 246 | -36,54 | 28,43 | -4 261 032 | 7 398 794 | |
| 2018-03-01 |
|
4 | NVCR |
Novocure Ltd
Restricted Stock Unit |
A - Award | 27 778 | 27 778 | |||||
| 2018-03-01 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 202 758 | 202 758 | |||||
| 2018-02-26 |
|
4 | NVCR |
Novocure Ltd
Restricted Stock Units |
M - Exercise | 53 334 | 106 666 | 100,00 | ||||
| 2018-02-26 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 53 334 | 410 124 | 14,95 | 21,55 | 1 149 348 | 8 838 172 | |
| 2018-01-31 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | -13 974 | 356 790 | -3,77 | 24,02 | -335 588 | 8 568 383 |
| 2018-01-26 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | -6 456 | 370 764 | -1,71 | 22,43 | -144 840 | 8 318 053 |
| 2018-01-25 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | -10 600 | 377 220 | -2,73 | 22,17 | -235 007 | 8 363 156 |
| 2018-01-25 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | -10 248 | 387 820 | -2,57 | 22,03 | -225 794 | 8 544 838 |
| 2018-01-17 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -14 900 | 398 068 | -3,61 | 22,20 | -330 755 | 8 836 433 | |
| 2018-01-16 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -22 895 | 412 968 | -5,25 | 22,02 | -504 237 | 9 095 166 | |
| 2018-01-16 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -313 525 | 435 863 | -41,84 | 22,35 | -7 007 503 | 9 741 843 | |
| 2018-01-10 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
A - Award | 283 | 749 388 | 0,04 | 15,04 | 4 258 | 11 274 542 | |
| 2017-11-08 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | -6 919 | 749 105 | -0,92 | 22,00 | -152 218 | 16 480 310 |
| 2017-11-06 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | -2 300 | 756 024 | -0,30 | 22,00 | -50 600 | 16 632 528 |
| 2017-11-02 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -15 716 | 758 324 | -2,03 | 22,01 | -345 870 | 16 688 815 | |
| 2017-11-02 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | -150 | 774 040 | -0,02 | 22,00 | -3 300 | 17 028 880 |
| 2017-09-27 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | -900 | 774 190 | -0,12 | 22,05 | -19 845 | 17 070 890 |
| 2017-09-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -1 772 | 775 090 | -0,23 | 22,00 | -38 984 | 17 051 980 | |
| 2017-09-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -35 500 | 776 862 | -4,37 | 22,01 | -781 518 | 17 102 306 | |
| 2017-07-18 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -354 780 | 0 | -100,00 | ||||
| 2017-07-18 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 354 780 | 812 362 | 77,53 | 0,38 | 134 816 | 308 698 | |
| 2017-07-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -5 183 | 457 582 | -1,12 | 20,19 | -104 645 | 9 238 581 | |
| 2017-07-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -2 200 | 462 765 | -0,47 | 19,40 | -42 680 | 8 977 641 | |
| 2017-07-11 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -203 900 | 464 965 | -30,48 | 18,08 | -3 685 900 | 8 405 172 | |
| 2017-07-11 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -70 459 | 668 865 | -9,53 | 18,03 | -1 270 658 | 12 062 311 | |
| 2017-07-07 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -5 050 | 739 324 | -0,68 | 18,09 | -91 344 | 13 372 893 | |
| 2017-07-07 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -155 088 | 744 374 | -17,24 | 18,14 | -2 813 917 | 13 505 922 | |
| 2017-07-07 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
A - Award | 2 545 | 899 462 | 0,28 | 6,67 | 16 983 | 6 002 110 | |
| 2017-06-21 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -124 720 | 896 917 | -12,21 | 15,51 | -1 934 906 | 13 914 770 | |
| 2017-06-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -9 212 | 1 021 637 | -0,89 | 15,02 | -138 346 | 15 342 944 | |
| 2017-06-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -33 245 | 1 030 849 | -3,12 | 15,19 | -504 892 | 15 655 504 | |
| 2017-06-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -5 402 | 1 064 094 | -0,51 | 15,01 | -81 068 | 15 968 859 | |
| 2017-06-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -88 700 | 1 069 496 | -7,66 | 15,23 | -1 351 078 | 16 290 563 | |
| 2017-06-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -5 100 | 1 158 196 | -0,44 | 15,08 | -76 934 | 17 471 387 | |
| 2017-06-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | -175 501 | 1 163 296 | -13,11 | 15,13 | -2 654 979 | 17 598 342 | |
| 2017-02-28 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -342 954 | 0 | -100,00 | ||||
| 2017-02-28 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 342 954 | 1 338 797 | 34,44 | 0,17 | 58 302 | 227 595 | |
| 2017-02-24 |
|
4 | NVCR |
Novocure Ltd
Restricted Stock Unit |
A - Award | 160 000 | 160 000 | |||||
| 2017-02-24 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 375 000 | 375 000 | |||||
| 2017-01-06 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
A - Award | 3 156 | 995 843 | 0,32 | 6,67 | 21 060 | 6 645 260 | |
| 2016-04-14 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -59 130 | 0 | -100,00 | ||||
| 2016-04-14 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 59 130 | 992 687 | 6,33 | 0,17 | 10 052 | 168 757 | |
| 2016-03-04 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
P - Purchase | 10 000 | 933 557 | 1,08 | 15,00 | 150 000 | 14 003 355 | |
| 2016-02-26 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 100 000 | 100 000 | |||||
| 2015-10-05 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 413 910 | 413 910 | |||||
| 2015-10-01 | 3 | NVCR |
Novocure Ltd
Ordinary Shares |
1 847 114 | ||||||||
| 2015-10-01 | 3 | NVCR |
Novocure Ltd
Ordinary Shares |
1 847 114 |